Your browser doesn't support javascript.
loading
A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial.
Tan, Amabel Cl; Goubier, Anne; Kohrt, Holbrook E.
Afiliación
  • Tan AC; Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia ; PX Biosolutions, Melbourne, Victoria 3205 Australia.
  • Goubier A; PX Biosolutions, Melbourne, Victoria 3205 Australia ; DROIA, Meise, 1860 Belgium.
  • Kohrt HE; Department of Medicine, Division of Oncology, Stanford University, CCSR 1110, 269 Campus Drive, Stanford, California 94305 USA.
J Immunother Cancer ; 3: 48, 2015.
Article en En | MEDLINE | ID: mdl-26579225
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Immunother Cancer Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Immunother Cancer Año: 2015 Tipo del documento: Article